Ibiden Co Stock (OTC:IBIDY), Trade Ideas

Ibiden Company Limited is a provider of electronic and ceramic products. The company operates through three segments: ceramic, electron and other. The ceramic segment, which contributes the largest portion of revenue, provides environment-related ceramics products, graphite and specialty products, ceramic fibre, and fine ceramics products. Electron, the next- largest segment, offers package substrates in computers, information technology infrastructure, mobile device wiring boards, mobile devices and home appliances. The other segment includes the processing of agriculture, livestock and fisheries, the sale of oil products and synthetic resin production. The company is headquartered in Japan and generates the majority of revenue in Asia.

News

Tech

Media

IBIDY

INTC

TOELY

Intel CEO Looks To Meet TSMC On His Asia Visit To Meet Customers, Suppliers

IBIDEN CO LTD UNSP/ADR by Ibiden Co. Ltd.

Ibiden Co Ltd

Wedbush analyst Richard Anderson downgrades First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) from Outperform to Neutral and lowers the price target from $59 to $49.

Downgrades

Price Target

Analyst Ratings

Wedbush Downgrades First Industrial Realty to Neutral, Lowers Price Target to $49

Truist Securities analyst Miller Jump downgrades HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) from Buy to Hold and raises the price target from $27 to $35.

Truist Securities Downgrades HashiCorp to Hold, Raises Price Target to $35

Elon Musk&nbsp;reacted to a user&#8217;s jest about the whereabouts of a former&nbsp;OpenAI chief scientist&nbsp;Ilya Sutskever, after Greg Brockman shared a photo with Sam Altman and&nbsp;Nvidia&nbsp;CEO&nbsp;Jensen Huang. 
What Happened: On Wednesday, Brockman, the president of ChatGPT&#8217;s parent company, took to X, formerly Twitter, and <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">shared the photo</a> saying, &#8220;First NVIDIA DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &#8216;to advance AI, computing, and humanity.'&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">First <a href="https://twitter.com/nvidia?ref_src=twsrc%5Etfw">@NVIDIA</a> DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &quot;to advance AI, computing, and humanity&quot;: <a href="https://t.co/rEJu7OTNGT">pic.twitter.com/rEJu7OTNGT</a>
&mdash; Greg Brockman (@gdb) <a href="https://twitter.com/gdb/status/1783234941842518414?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Following this, an X user, humorously commented,&nbsp;&#8220;Tell the truth. Is Ilya&nbsp;in the box?,&#8221; to which Tesla and SpaceX CEO&nbsp;Elon Musk responded&nbsp;with a face with tears&nbsp;of joy emoji.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Meta&#8217;s Massive $1B Bet On Nvidia H100 GPU Cluster Will Dwarf Every Other Company&#8217;s Target, But Zuckerberg Reveals Original Goal Was This, Not AI</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1783262978193948851?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/news/24/03/37809836/nvidia-reveals-blackwell-gpu-highlights-partnerships-with-top-companies-at-gtc-the-whole-industry-is">DGX H2000 is being hailed</a> as the most potent GPU globally. The H200 GPU succeeds the highly acclaimed H100 GPU, boasting 1.8 times the memory capacity and 1.4 times the bandwidth of its predecessor.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The mention of&nbsp;Sutskever, OpenAI&#8217;s chief scientist, in the user&#8217;s comment has sparked renewed interest in <a href="https://www.benzinga.com/news/24/03/37814793/sam-altman-laughs-off-speculation-about-openais-ilya-sutskevers-whereabouts-i-really-hope-we-work-to">Sutskever&#8217;s mysterious absence</a>. Sutskever has been missing from the public eye since his <a href="https://www.benzinga.com/23/11/35861681/sam-altman-and-greg-brockman-shocked-and-saddened-after-removal-from-openai-over-google-meet">controversial &#8220;palace coup&#8221; in November</a>. 
His absence has been a subject of speculation, with even Sam Altman, OpenAI&#8217;s CEO, addressing the issue in a podcast. &#8220;I love Ilya. I have tremendous respect for Ilya. I really hope we work together for certainly the rest of my career,&#8221; the OpenAI CEO said in a conversation with Lex Fridman. 
Last year, following OpenAI employees&#8217; <a href="http://benzinga.com/news/23/11/35871393/openais-internal-strife-cto-coo-and-other-employees-unite-in-support-of-sam-altman" target="_blank" rel="noreferrer noopener">open rebellion</a> against the sudden firing of Altman and Brockman, Sutskever said that he would try to reunite the company. &#8220;I deeply regret my participation in the board's actions. I never intended to harm OpenAI,&#8221; he said at the time. 
Helen Toner, another board member who was part of Sutskever&#8217;s bid to remove Altman <a href="https://www.benzinga.com/news/23/11/35912540/sam-altman-tried-to-push-out-another-board-member-before-losing-and-getting-ousted-himself-report">left ChatGPT-parent</a> but Sutskever is still a part of it.
Check out more of Benzinga's Future Of Consumer Tech by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38357333/elon-musk-reacts-to-tucker-carlson-saying-theres-ton-of-evidence-that-aliens-live-among-us-with-6000?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Says He Feels &#8216;Like A Wince&#8217; When Saying &#8216;GPU&#8217; As He Boasts Rapid Progress With AI Compute: &#8216;Need A New Word&#8217;</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

General

Elon Musk Laughs As X User Quip On Nvidia CEO Jensen Huang's Picture With Sam Altman And Greg Brockman: 'Is Ilya In The Box?'

Retail pharmacy giant&nbsp;Walgreens Boots Alliance Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is bolstering its specialty pharmacy services, aiming&nbsp;to enhance patient outcomes and value for stakeholders.
The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37967312/walgreens-challenges-nearly-1b-arbitration-award-over-alleged-breach-of-covid-19-test-business-con" rel="noreferrer noopener">Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business&nbsp;Contract</a>
Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company&#8217;s healthcare offerings.
Anchored by an 18,000-square-foot Innovation Center in Pittsburgh, Pennsylvania, the initiative focuses on managing therapy complexities and ensuring patient success.
Under the expanded business, Walgreens will operate four central specialty pharmacies, each with national accreditations and expertise in dispensing intricate medications.
Additionally, the company&#8217;s expansive network comprises nearly 300 community-based specialty&nbsp;pharmacies,&nbsp;strategically positioned for swift medication access and tailored patient services.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37981845/walgreens-boots-alliance-cuts-higher-end-of-2024-profit-outlook-takes-5-8b-impairment-charge-relate" rel="noreferrer noopener">Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD&nbsp;Business</a>
With over 1,500 specialty-trained pharmacists and 5,000 patient advocacy support members, Walgreens Specialty Pharmacy&nbsp;is primed&nbsp;to address the burgeoning demand for specialized care.
Specialty medications constitute a significant portion of the U.S. prescription drug market, driving the need for tailored solutions.
Walgreens Specialty Pharmacy aims to meet this demand by streamlining care coordination across stakeholders, thereby enhancing patient access and driving cost efficiencies.
Effective August 1, 2024, AllianceRx Walgreens Pharmacy will transition to Walgreens Specialty Pharmacy, offering enhanced resources and clinical support to patients.
Walgreens&nbsp;stock lost over 48% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco High Yield Equity Dividend Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and&nbsp;Invesco Dow Jones Industrial Average Dividend ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DJD#NYSE">DJD</a>).
Price Action: WBA shares are trading higher by 0.79% at $17.94 in premarket at last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Equities

Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details

HSBC analyst Parash Jain upgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Hold to Buy and raises the price target from $150 to $170.

Upgrades

HSBC Upgrades United Parcel Service to Buy, Raises Price Target to $170

Keybanc analyst Kenneth Zener upgrades Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Sector Weight to Overweight and announces $400 price target.

Keybanc Upgrades Sherwin-Williams to Overweight, Announces $400 Price Target

PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.

Earnings

Earnings Beats

PRTC

PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY

The CHIPS and Science Act grants of $6.1 billion will support Micron&#39;s plans to invest approximately $50 billion in gross capex for U.S. domestic leading-edge memory manufacturing through 2030. These grants and additional state and local incentives will support the construction of one leading-edge memory manufacturing fab to be co-located with the company&#39;s existing leading-edge R&amp;D facility in Boise, Idaho and the construction of two leading-edge memory fabs in Clay, New York.

Government

Large Cap

Micron Technology And The Biden-Harris Administration Have Signed A Non-binding Preliminary Memorandum Of Terms For $6.1B In Funding Under The CHIPS And Science Act To Support Planned Memory Manufacturing In Idaho And New York

Full-year 2024 revenues are expected to increase&nbsp;1.5%&nbsp;to&nbsp;3.5%&nbsp;on a reported basis and increase&nbsp;1%&nbsp;to&nbsp;3%&nbsp;organically, after excluding the expected impacts of acquisitions, divestitures and foreign currency movements.

Guidance

ALLE

Allegion Reaffirmed FY24 Outlook: Adjusted EPS At $7.00-$7.15 Vs. $7.07 Estimate, Revenue Growth At 1.5%-3.5%

Needham analyst Quinn Bolton upgrades Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and announces $150 price target.

SLAB

Needham Upgrades Silicon Laboratories to Buy, Announces $150 Price Target

. This will enable TCO to expand Tengiz crude oil production by an incremental 12 million tons per annum (260,000 barrels a day)

Commodities

Markets

Chevron announced that its 50% owned affiliate Tengizchevroil has commenced operations at its Wellhead Pressure Management Project at the Tengiz oil field in Kazakhstan, The final phase of TCO's expansion project, is on track to conclude in 1H 2025

Needham analyst Ami Fadia reiterates Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and maintains $294 price target.

Reiteration

BIIB

Needham Reiterates Buy on Biogen, Maintains $294 Price Target

Allegion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLE#NYSE">ALLE</a>) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.45 by 6.9 percent. The company reported quarterly sales of $893.900 million which beat the analyst consensus estimate of $884.249 million by 1.09 percent. This is a 3.15 percent decrease over sales of $923.000 million the same period last year.

Allegion Q1 2024 Adj EPS $1.55 Beats $1.45 Estimate, Sales $893.900M Beat $884.249M Estimate

Keefe, Bruyette &amp; Woods analyst Catherine Mealor upgrades Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) from Market Perform to Outperform and raises the price target from $30 to $36.

TRMK

Keefe, Bruyette & Woods Upgrades Trustmark to Outperform, Raises Price Target to $36

Mark Zuckerberg, the CEO of Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), has seemingly <a href="https://www.benzinga.com/general/gaming/24/02/37305770/mark-zuckerberg-on-a-mission-to-outdo-apple-vision-pro-meta-ceo-reportedly-eyes-south-korean-colla">taken a dig</a> at Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Vision Pro.
What Happened: Zuckerberg expressed his skepticism about the mainstream success of augmented reality (AR) glasses, particularly those without &#8220;full holographic displays," in a subtle jab at Apple Vision Pro during Meta&#8217;s <a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding">first-quarter earnings call</a>.
&#8220;Now, it seems pretty clear that there&#8217;s also a meaningful market for fashionable AI glasses without a display."
Meta&#8217;s latest version of Ray-Ban smart glass, <a href="https://www.benzinga.com/general/entertainment/23/09/34964097/watch-mark-zuckerberg-unveils-metas-ai-smart-glasses-that-can-decode-anything-youre-looking">launched in September</a>, starts at $299 and comes with Meta AI, a camera, call-making capabilities, and built-in speakers.
Zuckerberg also emphasized the potential of these glasses as a &#8220;pretty meaningful and growing platform sooner than then I would have expected so.&#8221;
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Despite Meta&#8217;s Quest virtual reality headset competing with Apple&#8217;s Vision Pro, Zuckerberg has previously stated that he does not envision a future where people walk around with virtual reality headsets.
See Also: <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">Jensen Huang Hand-Delivers Nvidia&#8217;s First DGX H200 GPU To OpenAI&#8217;s Sam Altman To &#8216;Advance AI, Computing, And Humanity&#8217;</a>
Why It Matters: This isn&#8217;t the first time Zuckerberg has taken a swipe at the Apple Vision Pro. In February, he <a href="https://www.benzinga.com/general/entertainment/24/02/37116135/mark-zuckerberg-finally-tries-apples-vision-pro-and-says-metas-quest-3-is-the-better-produc">posted a video</a> reviewing Apple&#8217;s competing device, stating that the Quest not only had better value but was also &#8220;the better product period.&#8221;
This was echoed by Meta&#8217;s CTO, Andrew Bosworth, who <a href="https://www.benzinga.com/general/entertainment/24/02/37175237/metas-tech-chief-echoes-zuckerbergs-review-of-apple-vision-pro-says-way-too-much-weight-dis">highlighted several issues</a> with the Vision Pro, dismissing reports about its technological superiority.
In March, Zuckerberg also <a href="https://www.benzinga.com/news/24/03/37616210/mark-zuckerberg-refutes-analysts-claim-quest-not-basically-just-the-same-as-apples-vision-pro">refuted the notion</a> that the Vision Pro was comparable to Meta&#8217;s Quest lineup.
Meanwhile, Apple&#8217;s Vision Pro has been facing challenges, with reports of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38397921/apple-in-trouble-tim-cook-reportedly-cuts-vision-pro-shipment-forecasts-by-up-to-50">a significant drop in demand</a> leading to a cut in shipment forecasts by up to 50%.
Price Action:&nbsp;Meta stock closed 0.52% lower at $493.50 on Wednesday, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38420928/meta-ceo-mark-zuckerberg-more-than-50-of-the-content-people-see-on-instagram-is-now-ai-recommended" target="_blank" rel="noreferrer noopener">Meta CEO Mark Zuckerberg: ‘More Than 50% Of The Content People See On Instagram Is Now AI Recommended'</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Ray-Ban

AAPL

Mark Zuckerberg Shades Apple Vision Pro Once Again, Calls It 'Fashionable AI Glasses Without A Display'

BHP Group Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>), the world&#8217;s largest mining company, has initiated a bid to acquire rival Anglo American Plc (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AAUKF#OTC">AAUKF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NGLOY#OTC">NGLOY</a>), potentially triggering significant upheaval in the industry after years of dormancy.
Anglo American, valued at £27 billion ($34 billion),&nbsp;<a target="_blank" href="https://www.angloamerican.com/media/press-releases/2024/25-04-2024" rel="noreferrer noopener">disclosed</a>&nbsp;that it had received an unsolicited merger proposal&nbsp;in the form of&nbsp;a stock exchange offer.
The proposed merger is contingent on Anglo divesting its South African platinum and iron ore units.
If successful, this deal would signify a resurgence in large-scale transactions for BHP, which, under CEO Mike Henry, has rekindled its appetite for transformative acquisitions in recent years, according to a report from&nbsp;<a target="_blank" href="https://www.bloomberg.com/news/articles/2024-04-24/bhp-group-is-said-to-weigh-potential-takeover-of-anglo-american?srnd=homepage-asia&amp;sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a>.
The report further noted that a merger with Anglo would establish the world&#8217;s leading copper producer, positioning itself to meet the surging demand from emerging energy&nbsp;sectors,&nbsp;while potentially attracting other competitors seeking to bolster their output.
Anglo American, long identified as an attractive target among&nbsp;major&nbsp;mining firms, possesses substantial copper operations in South America, a coveted asset in an industry focused on augmenting reserves and production.
Nevertheless, its intricate corporate structure and diverse commodity portfolio,&nbsp;coupled with&nbsp;significant exposure to South Africa,&nbsp;have deterred suitors, as per the report.
BHP produced approximately 1.2 million tons of copper in 2023, while Anglo yielded 826,000 tons, positioning the combined entity to command around 10% of&nbsp;global&nbsp;mine supply.
However, regulatory hurdles loom as governments view copper as a strategic resource, the report mentioned.
Anglo American&nbsp;stated that its board is evaluating the proposal, with no assurance of a forthcoming offer.
BHP&nbsp;stock gained over 3% in the last 12 months. Investors can gain exposure to the stock via Pacer&nbsp;Trendpilot International ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PTIN#NYSE">PTIN</a>) and&nbsp;Avantis International Equity ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVDE#NYSE">AVDE</a>).
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/commodities/24/03/37789877/bhp-to-slash-australian-workforce-as-nickel-market-downturn-continues" rel="noreferrer noopener">BHP To Slash Australian Workforce As Nickel Market Downturn Continues</a>
Price Action: BHP shares are trading lower by 3.12% at $57.39 in premarket at&nbsp;the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Movers

AAUKF

AVDE

NGLOY

PTIN

World's Largest Miner BHP Bids To Takeover Anglo American As Hunt For Resources Intensify

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) with a Buy and maintains $33 price target.

DAWN

Needham Reiterates Buy on Day One Biopharmaceutical, Maintains $33 Price Target

<a href="https://www.bloomberg.com/news/articles/2024-04-25/honda-s-11-billion-electric-vehicle-expansion-includes-government-aid-in-canada?sref=y3YMCJ4e" title="https://www.bloomberg.com/news/articles/2024-04-25/honda-s-11-billion-electric-vehicle-expansion-includes-government-aid-in-canada?sref=y3YMCJ4e">https://www.bloomberg.com/news/articles/2024-04-25/honda-s-11-billion-electric-vehicle-expansion-includes-government-aid-in-canada?sref=y3YMCJ4e</a>

Bloomberg Reported Earlier, Honda's $11B Electric-Vehicle Plan Includes Government Aid From Canada

Goldman Sachs analyst Eric Sheridan maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and lowers the price target from $555 to $500.